Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medical News

Fri, Dec 13th, 2019
US approves fish oil-based drug for cutting heart risks

TRENTON, N.J. (AP) — U.S. regulators on Friday approved expanded use of a fish oil-based drug for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills....

Anixa Biosciences to Host Conference Call to Discuss Plans for 2020

SAN JOSE, Calif. , Dec. 13, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer,...

ANIX : 3.26 (-15.10%)
ITUS : 4.64 (+0.65%)
West Announces First-Quarter Dividend, Share Repurchase Program and Participation in Upcoming Investor Conference

EXTON, Pa. , Dec. 13, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the...

WST : 146.37 (-0.03%)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH PLAINFIELD, N.J. , Dec. 13, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on December 9, 2019 it approved non-statutory stock options to purchase an aggregate...

PTCT : 48.25 (+1.11%)
In surprise decision, US approves muscular dystrophy drug

WASHINGTON (AP) — U.S. health regulators approved a second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months...

How tramadol, touted as safer opioid, became 3rd world peril

KAPURTHALA, India (AP) — Reports rolled in with escalating urgency — pills seized by the truckload, pills swallowed by schoolchildren, pills in the pockets of dead terrorists.

Takeda Partners with MiTest Health to Launch Innovative Disease Risk Prediction Tool to Redefine Crohn's Disease Management

LEXINGTON, Mass. , Dec. 13, 2019 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A. (TSE: 4502) (NYSE:TAK) ("Takeda") and MiTest Health LLC ("MiTest"), a pioneering health technology company, today...

TAK : 20.23 (-0.44%)
Boston Scientific Receives FDA Clearance For World's First Single-Use Duodenoscope, EXALT™ Model D

MARLBOROUGH, Mass. , Dec. 13, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the EXALT™ Model D Single-Use...

BSX : 45.09 (+0.94%)
Tramadol is an odd, unpredictable opioid, scientists say

Scientists who’ve studied the curious chemistry of the opioid tramadol use an array of adjectives to describe it: “unpredictable,” “messy,” “crazy.”

Kelyniam Global Releases Q3 Financials

CANTON, Conn. , Dec. 13, 2019 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, released today financial performance for the third quarter of 2019.    

KLYG : 0.0630 (unch)
Abbott Raises Quarterly Dividend 12.5%, Increasing Payouts for 48 Straight Years

ABBOTT PARK, Ill., Dec. 13, 2019 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to 36 cents per share – a 12.5% increase....

ABT : 86.35 (+0.44%)
Patent Detecting How Patients Respond to Folate-based Cancer Treatment Approved in the USA

GOTHENBURG, Sweden , Dec. 13, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announces the approval from the United States Patent and Trademark Office...

PDL BioPharma to Exchange Approximately 80% of Convertible Notes Due 2021 and 2024

INCLINE VILLAGE, Nev. , Dec. 13, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has entered into separate, privately negotiated exchange...

PDLI : 3.36 (-2.04%)
OncoSec Presents Interim Data of 28.5% Objective Response Rate (ORR) from Ongoing KEYNOTE-890 Study Evaluating TAVO™ in Combination with KEYTRUDA® for Heavily Pretreated, Late-Stage, Metastatic Triple Negative Breast Cancer (mTNBC) at the 2019 San Antonio Breast Cancer Symposium

SAN DIEGO and PENNINGTON, N.J. , Dec. 13, 2019 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (Nasdaq:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today...

ONCS : 2.02 (-16.18%)
Phio Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders

MARLBOROUGH, Mass. , Dec. 13, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary...

PHIO : 0.14 (-12.27%)
Boehringer Ingelheim and Lilly provide update on Jardiance® phase III exercise ability studies in chronic heart failure

RIDGEFIELD , Conn. and INDIANAPOLIS , Dec. 13, 2019 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced today results from the EMPERIAL-Reduced and EMPERIAL-Preserved...

LLY : 121.53 (-0.14%)
BioLineRx Announces Updated Phase 2a Data From Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second-line Metastatic Pancreatic Cancer

BLRX : 2.39 (-9.13%)
Aethlon Medical Announces Pricing of $5 Million Public Offering

SAN DIEGO , Dec. 13, 2019 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD) (the "Company"),  a medical device technology company focused on developing products to diagnose and treat life and...

AEMD : 1.04 (-47.85%)
CHMP Issues Positive Opinion to Expand CYRAMZA® (ramucirumab) Label to Include Results from RELAY Study in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

INDIANAPOLIS , Dec. 13, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued...

LLY : 121.53 (-0.14%)
Anixa Biosciences Provides Update on CAR-T Program

SAN JOSE, Calif. , Dec. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today...

ANIX : 3.26 (-15.10%)

Chart of the Day

Globe Life Inc (GL)

The Barchart Chart of the Day belongs to the financial services company Globe Life (GL). I found the stock by sorting Barchart's New All-Time High list first by the most frequent number of new highs in the last month, then used the Flipchart fea...
Read More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar